Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "Gates"

251 News Found

India Pharma 2026 concludes with strong call for funding, infrastructure and speed to power innovation
Policy | April 15, 2026

India Pharma 2026 concludes with strong call for funding, infrastructure and speed to power innovation

The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions


AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial
Clinical Trials | April 14, 2026

AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial

Highlights Mirvetuximab-based regimen promise


ICPA to host India Unlimited 4.0 in San Diego to spotlight India’s global biopharma role
Biopharma | April 13, 2026

ICPA to host India Unlimited 4.0 in San Diego to spotlight India’s global biopharma role

This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing


C4 Therapeutics and Roche launch bold push into next-generation cancer drug modality
News | April 12, 2026

C4 Therapeutics and Roche launch bold push into next-generation cancer drug modality

The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation


India Pharma Conference 2026 to spotlight innovation, global partnerships in New Delhi
Policy | April 09, 2026

India Pharma Conference 2026 to spotlight innovation, global partnerships in New Delhi

Discussions are likely to centre on how the country can move up the pharmaceutical value chain


Zealand Pharma launches major US research hub in Cambridge, Massachusetts
R&D | March 26, 2026

Zealand Pharma launches major US research hub in Cambridge, Massachusetts

The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities


SK bioscience bags fresh backing to accelerate fight against respiratory disease
News | March 20, 2026

SK bioscience bags fresh backing to accelerate fight against respiratory disease

RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute


BioNTech co-founders launch new mRNA venture, aiming to revolutionize next-gen therapies
News | March 14, 2026

BioNTech co-founders launch new mRNA venture, aiming to revolutionize next-gen therapies

The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission


Merck delivers resilient 2025 performance despite global headwinds
News | March 06, 2026

Merck delivers resilient 2025 performance despite global headwinds

Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results


SEOPRO stuns pharma leaders with AI-driven portfolio management at EBMPPPM 2026
Digitisation | March 02, 2026

SEOPRO stuns pharma leaders with AI-driven portfolio management at EBMPPPM 2026

During live demonstrations, industry leaders highlighted SEOPRO’s ability to spot portfolio risk, execution bottlenecks, and decision delays early—before they escalate into costly program disruptions